Agenus
AGEN
#9058
Rank
S$0.14 B
Marketcap
S$4.06
Share price
-4.79%
Change (1 day)
18.86%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): S$24.46 Million

According to Agenus 's latest financial reports the company's current earnings are S$0.10 Billion. In 2024 the company made an earning of -S$0.15 Billion, an increase over its 2023 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$24.46 M-116.69%
2024 -S$0.15 Billion-28.13%
2023 -S$0.21 Billion-5.5%
2022 -S$0.22 Billion-556.26%
2021 S$47.28 M-130.37%
2020 -S$0.16 Billion73.75%
2019 -S$89.62 Million-48.74%
2018 -S$0.18 Billion34.32%
2017 -S$0.14 Billion-7.16%
2016 -S$0.15 Billion26.55%
2015 -S$0.12 Billion110.24%
2014 -S$52.7 Million49.12%
2013 -S$35.34 Million
2011 -S$24.4 Million-12.25%
2010 -S$27.81 Million-21.41%
2009 -S$35.38 Million-26.86%
2008 -S$48.38 Million13.72%
2007 -S$42.54 Million-33.4%
2006 -S$63.87 Million-31.84%
2005 -S$93.71 Million9.74%
2004 -S$85.39 Million-0.8%
2003 -S$86.08 Million17.37%
2002 -S$73.34 Million37.83%
2001 -S$53.21 Million55.99%
2000 -S$34.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.40 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.51 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.26 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.91 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.33 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA